Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeCost of RevenueDepreciation & Amortization - TotalEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Gross ProfitIncome from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeNet Income towards Common StockholdersOperating ExpensesOperating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares Outstanding (Diluted Average)Shares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Health Catalyst (HCAT) Interest Expenses (2018 - 2023)

Historic Interest Expenses for Health Catalyst (HCAT) over the last 6 years, with Q4 2023 value amounting to -$2.6 million.

  • Health Catalyst's Interest Expenses fell 15596.87% to -$2.6 million in Q4 2023 from the same period last year, while for Sep 2024 it was -$2.6 million, marking a year-over-year increase of 6517.57%. This contributed to the annual value of -$9.1 million for FY2023, which is 64266.98% down from last year.
  • According to the latest figures from Q4 2023, Health Catalyst's Interest Expenses is -$2.6 million, which was down 15596.87% from -$2.6 million recorded in Q3 2023.
  • In the past 5 years, Health Catalyst's Interest Expenses ranged from a high of $4.4 million in Q3 2021 and a low of -$2.6 million during Q4 2023
  • For the 5-year period, Health Catalyst's Interest Expenses averaged around $1.2 million, with its median value being $1.1 million (2019).
  • Per our database at Business Quant, Health Catalyst's Interest Expenses skyrocketed by 72262.63% in 2020 and then plummeted by 173591.55% in 2023.
  • Health Catalyst's Interest Expenses (Quarter) stood at $495000.0 in 2019, then soared by 722.63% to $4.1 million in 2020, then grew by 7.47% to $4.4 million in 2021, then crashed by 123.35% to -$1.0 million in 2022, then tumbled by 155.97% to -$2.6 million in 2023.
  • Its Interest Expenses stands at -$2.6 million for Q4 2023, versus -$2.6 million for Q3 2023 and -$2.1 million for Q2 2023.